Here are three things to know:
1. The patent covers Kuros’ technology for the production of osteoinductive calcium phosphates, which feature a surface topography designed to instruct stem cells and osteoprogenitor cells to differentiate into bone-forming cells.
2. The company is forming a patent portfolio and submitting patent applications to protects its proprietary MagnetOs product family.
3. MagnetOs is a bone graft substitute designed to fill bony voids or gaps to promote the bone formation at the implantation site.
More articles on biologics:
LifeNet Health unveils moldable osteobiologic solution for spine: 5 insights
ApoGraft-enriched stem cells show positive results in orthopedic application: 3 notes
Kuros Biosciences seeks spinal fusion product expansion: 4 things to know
